03.11.21 -- The Past, Present, And Future Of Biosimilar Manufacturing

Great changes are afoot in the world of biosimilar commercialization. Here, Abraxeolus Consulting manager, Edric Engert walks you through his view as to what has been, what has changed, and what the new flexible biosimilar business model of the future will look like.

A recent publication entitled "Approval of Biosimilars: A Review of Unsuccessful Regulatory Filings" revealed the most common manufacturing issues the FDA and EMA flagged in biosimilar applications. Here, the lead author discusses his findings from the past, current manufacturing challenges, and which technologies could be most impactful for the future biosimilar industry.